E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappaB-α/nuclear factor kappaB pathway

Hongjiu Ren; Yitong Xu; Qiongzi Wang; Jun Jiang; Wudumuli; Linping Hui; Qingfu Zhang; Xiupeng Zhang; Enhua Wang; Limei Sun; Xueshan Qiu

doi:10.18632/oncotarget.19075

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappaB-α/nuclear factor kappaB pathway

Hongjiu Ren, Yitong Xu, Qiongzi Wang, Jun Jiang, Wudumuli , Linping Hui, Qingfu Zhang, Xiupeng Zhang, Enhua Wang, Limei Sun and Xueshan Qiu _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:10880-10890. https://doi.org/10.18632/oncotarget.19075

Metrics: PDF 1620 views | HTML 2456 views | ?

Abstract

Hongjiu Ren1, Yitong Xu1, Qiongzi Wang1, Jun Jiang1, Wudumuli1, Linping Hui1,2, Qingfu Zhang1, Xiupeng Zhang1, Enhua Wang1, Limei Sun1 and Xueshan Qiu1

1Department of Pathology, College of Basic Medical Sciences and First Affiliated Hospital, China Medical University, Shenyang, China

2Fouth Affiliated Hospital, China Medical University, Shenyang, China

Correspondence to:

Xueshan Qiu, email: [email protected]

Limei Sun, email: [email protected]

Keywords: tripartite motif-containing 71, non-small cell lung cancer, inhibitor of kappaB, nuclear factor kappaB, ubiquitination

Received: November 24, 2016 Accepted: June 15, 2017 Published: July 07, 2017

ABSTRACT

Tripartite motif-containing (TRIM) 71 belongs to the TRIM protein family. Many studies have shown that TRIM71 plays conserved roles in stem cell proliferation, differentiation, and embryonic development; however, the relationship between TRIM71 and tumorigenesis is not clear. In this study, we demonstrate that TRIM71 expression in non-small cell lung cancer (NSCLC) is associated with tumor size, lymph node metastasis, TNM stage, and poor prognosis. We found that TRIM71 was highly expressed in NSCLC cell lines compared with that in human normal bronchial epithelial cells. Moreover, by altering the expression of TRIM71 in selected cell lines, we found that TRIM71 promoted the proliferation of NSCLC cells through activation of the inhibitor of kappaB/nuclear factor kappaB pathway. These results suggested that TRIM71 plays a role in promoting the development of NSCLC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19075

Publication Alerts

Research Papers:

E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappaB-α/nuclear factor kappaB pathway

Abstract